Jump to main content
Jump to site search

Issue 60, 2015
Previous Article Next Article

Development of crystalline–amorphous parylene C structure in micro- and nano-range towards enhanced biocompatibility: the importance of oxygen plasma treatment time

Author affiliations

Abstract

The crystalline–amorphous parylene C structure was fabricated by Chemical Vapour Deposited (CVD) and functionalised in the micro- and nano-range with the oxygen plasma treatment. The evolution of thermal stability, structure and surface biocompatibility of parylene C films as an effect of oxygen plasma treatment time were evaluated by means of thermogravimetric/differential thermal analysis (TG/DTA), X-Ray Diffraction (XRD) and cells adhesion tests (crystal violet assay, fluorescence microscopy). The results are epitomized by a crystalline–amorphous parylene C structural model. It was found that the time of oxygen plasma treatment is critical for adhesion of osteoblast cells with the optimum of 5–8 minutes.

Graphical abstract: Development of crystalline–amorphous parylene C structure in micro- and nano-range towards enhanced biocompatibility: the importance of oxygen plasma treatment time

Back to tab navigation

Article information


Submitted
09 Apr 2015
Accepted
22 May 2015
First published
27 May 2015

RSC Adv., 2015,5, 48816-48821
Article type
Paper
Author version available

Development of crystalline–amorphous parylene C structure in micro- and nano-range towards enhanced biocompatibility: the importance of oxygen plasma treatment time

M. Golda-Cepa, K. Engvall and A. Kotarba, RSC Adv., 2015, 5, 48816
DOI: 10.1039/C5RA06366C

Social activity

Search articles by author

Spotlight

Advertisements